openPR Logo
Press release

BOC Sciences to Showcase Innovative Solutions at ACS Fall 2025

07-15-2025 03:18 PM CET | Health & Medicine

Press release from: ABNewswire

BOC Sciences to Showcase Innovative Solutions at ACS Fall 2025

BOC Sciences will present at ACS Fall 2025 (Booth #2230), one of the largest scientific conferences held by the American Chemical Society (ACS).
As the daunting challenges the world has been facing continue to bring an impact to the biopharmaceutical industry, this year's hybrid event, onsite in Washington, DC and virtually on 17-21 August, presents one more opportunity for BOC Sciences to demonstrate its world class capabilities for helping to make innovation in pharmaceuticals, biotech, and materials a reality.

Exhibition details:

Event Date: August 17-21, 2025

Venue: Washington, DC & Virtual

Exhibition Booth: #2230

Meeting Booking Channel: https://www.bocsci.com/events/boc-sciences-at-acs-fall-2025.html

At Booth #2230, BOC Sciences will spotlight its most advanced products and research solutions powering modern drug discovery and development:

Next-Gen Targeted Therapies: Including PROTACs and bioconjugation platforms [https://www.bocsci.com/xdc-bioconjugation.html] enabling novel cancer treatments

Precision Research Tools: High-purity inhibitors and stable isotope-labeled compounds for critical pathway studies

Synthetic Breakthroughs: Custom oligonucleotides and small molecule synthesis [https://www.bocsci.com/custom-synthesis.html] with unprecedented purity standards

Attendees will experience:

Live Tech Demonstrations: Interactive displays of novel techniques and their further applications

Expert-Led Sessions: Scheduled discussions on overcoming modern R&D hurdles

Exclusive Preview Access: First looks at upcoming expansions in the product catalog and technical platfo

Beyond product & technique displays, BOC Sciences will emphasize its growing role as a strategic collaborator, offering:

Dedicated project management for complex custom synthesis challenges

Integrated analytical support from mg to kg scale

"We are bringing the most innovative technology packages we have ever created to ACS 2025," said the company's Business Development Manager. "At a moment when scientists are facing some of their most difficult challenges, we are offering not just chemicals, but full scientific partnerships to help accelerate the research pace."

In recent years, BOC Sciences has increased its presence in industry and academia by attending important events like the Drug Discovery Chemistry Conference, World ADC San Diego, the Oligonucleotide Therapeutics Society Meeting, and the PODD (Partnership Opportunities in Drug Delivery) Conference. Such partnerships allow BOC Sciences to further establish connections with top scientists in the world. And the life sciences field is also benefiting from stronger academia-industry bonds, fostering groundbreaking innovations.

About

BOC Sciences is a reliable source of a variety of chemicals, APIs, custom synthesis, and analytical services. Dedicated to quality, innovation, and customer service, the company addresses pharmaceutical, biotechnology, and material science industries globally. With its rich product line and professional services, BOC Sciences serves as one of the top chemical suppliers for customers from all around the world.

Media Contact
Company Name: BOC Sciences
Contact Person: Alex Brown
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=boc-sciences-to-showcase-innovative-solutions-at-acs-fall-2025]
Country: United States
Website: https://www.bocsci.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BOC Sciences to Showcase Innovative Solutions at ACS Fall 2025 here

News-ID: 4105018 • Views:

More Releases from ABNewswire

Lupus Nephritis Clinical Trials, Companies, Therapies, Treatment, Pipeline | Hoffmann-La Roche, Qilu Pharmaceutical, Vera Therapeutics, Kyverna Therapeutics, Cabaletta Bio, Takeda, Nkarta Therapeutics
Lupus Nephritis Clinical Trials, Companies, Therapies, Treatment, Pipeline | Hof …
DelveInsight's, "Lupus Nephritis - Pipeline Insight, 2025" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. DelveInsight reports that the Lupus Nephritis pipeline involves over 35
Non Cystic Fibrosis Bronchiectasis Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies
Non Cystic Fibrosis Bronchiectasis Pipeline Outlook 2025: Clinical Trial Studies …
DelveInsight's, "Noncystic fibrosis bronchiectasis Pipeline Insight, 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Noncystic fibrosis bronchiectasis pipeline landscape. It covers the Non Cystic Fibrosis Bronchiectasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Cystic Fibrosis Bronchiectasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this
Parkinson's disease psychosis Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment, Pipeline | Vanda Pharmaceuticals, Sumitomo Pharma
Parkinson's disease psychosis Clinical Trials, Companies, Therapeutic Assessment …
DelveInsight's, "Parkinson's disease psychosis - Pipeline Insight, 2025," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Parkinson's disease psychosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. DelveInsight reports that the Parkinson's disease psychosis pipeline
Migraine Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies
Migraine Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals …
DelveInsight's, "Migraine Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Migraine pipeline landscape. It covers the Migraine pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Migraine Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead in

All 5 Releases


More Releases for BOC

Boc-D-Orn-OH Market | BOC Sciences, Bachem, Chem-Impex, Iris Biotech
The global boc-d-orn-oh market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the boc-d-orn-oh market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the boc-d-orn-oh market.
Sulfocostunolide B Market | ALB Technology, BOC Sciences, Biosynth, TRC
The global sulfocostunolide b market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the sulfocostunolide b market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Boc-L-2-Nitrophenylalanine Market | 3B Scientific Corporation, Alchem Pharmtech, …
The global boc-l-2-nitrophenylalanine market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the boc-l-2-nitrophenylalanine market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the boc-l-2-nitrophenylalanine market.
Jasmolin II Market | Altascientific, BOC Sciences, Biosynth, TRC
The global jasmolin ii market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the jasmolin ii market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Albaconazole Market | BOC Sciences, Biosynth, TRC, TargetMol
The global albaconazole market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the albaconazole market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the albaconazole market.
Levomedetomidine Market | Axios Research, BOC Sciences, Biosynth, SimSon Pharma
The global levomedetomidine market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the levomedetomidine market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the levomedetomidine market.